USPTO serial 79089041
Reviewed by CopyMark Law Group
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard J. McKenna
Richard J. McKenna FOLEY & LARDNER LLP3000 K Street, N.W. Suite 600Washington, DC 20007-5109UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceutical preparations, namely, antibacterial pharmaceuticals, anti-diabetic pharmaceuticals, balms for pharmaceutical purposes, cardiovascular pharmaceuticals, dermatological pharmaceutical products, digestives for pharmaceutical purposes, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders, ocular pharmaceuticals, pharmaceutical anti-allergic preparations and substances, pharmaceutical anti-allergic preparations and substances, anticoagulants, antidepressants, appetite suppressants, pharmaceutical preparations for use in chemotherapy, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations for the treatment of infectious diseases, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for wounds, pharmaceutical preparations for use in urology, pharmaceutical preparations for skin care, pharmaceutical preparations for the treatment of kidney diseases, pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders, and pharmaceutical preparations for the treatment of the thyroid gland ] | SECTION 71 - CANCELLED | — |
| 042 | [ Medical research laboratory services; ] [ consultation services related to research in the field of development of surgical products; ] [ product development; development of medical products; and ] scientific and technological services and research and design relating thereto for medical purposes, namely, medical and scientific research in the fields of [ cancer treatment, cardiovascular treatment, treatment of infectious diseases, and ] treatment of a wide variety of major medical human disorders | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 17, 2024 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 7, 2024 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 7, 2024 | INPC | INVALIDATION PROCESSED | — |
| Jan 31, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 31, 2023 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 31, 2023 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Apr 17, 2023 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Nov 2, 2022 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Oct 24, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 10, 2022 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Nov 29, 2020 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Nov 6, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 30, 2020 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Oct 12, 2018 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 5, 2018 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 5, 2018 | INPC | INVALIDATION PROCESSED | — |
| Aug 17, 2018 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 4, 2017 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Dec 4, 2017 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Dec 1, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 16, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 8, 2017 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Nov 29, 2016 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 10, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 23, 2012 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 23, 2012 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 29, 2012 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 29, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 20, 2011 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 13, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 13, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 24, 2011 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 24, 2011 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 11, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 11, 2011 | ALIE | ASSIGNED TO LIE | — |
| Jul 29, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 8, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 8, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 8, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 29, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 11, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 11, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 10, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 9, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 31, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 23, 2010 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 19, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 18, 2010 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |